![]() |
|
|
-Tocopherol Biokinetics1,2
Centre for Nutrition and Food Safety, School of Biomedical and Molecular Sciences, University of Surrey, Guildford, Surrey, GU2 7XH, UK
3To whom correspondence should be addressed. E-mail: j.lodge{at}surrey.ac.uk.
Vitamin E homeostasis in hyperlipidemia is poorly understood. The biokinetics of deuterated
-tocopherol (
-T) in blood components was investigated in normolipidemic (N; total cholesterol < 5.5 mmol/L and triglycerides < 1.5 mmol/L, n = 9), hypercholesterolemic (HC; total cholesterol > 6.5 mmol/L and triglycerides < 1.5 mmol/L, n = 10), and combined hypercholesterolemic and hypertriglyceridemic (HCT; total cholesterol > 6.5 mmol/L and triglycerides > 2.5 mmol/L, n = 6) subjects. Subjects ingested 150 mg hexadeuterated RRR-
-tocopheryl acetate, and blood was collected up to 48 h after ingestion. Labeled
-T was measured in plasma, lipoproteins, erythrocytes, platelets, and lymphocytes by liquid chromatography/mass spectroscopy. In plasma, HC had an earlier time of maximum concentration (6 h) compared with N and HCT (12 h) (P < 0.05). HCT had a lower uptake of labeled
-T (P < 0.005) and a longer half-life (P < 0.05). In chylomicrons, the maximum labeled
-T concentration was higher in HC compared with N and HCT (P < 0.00005); however, HCT had a lower uptake of labeled
-T in LDL. In all groups, the lowest density LDL subfraction contained more labeled
-T than denser subfractions (P < 0.05). In platelets, lymphocytes, and erythrocytes, the areas under the labeled
-T concentration vs. time curves were in the order N > HC > HCT. In lymphocytes, differences in labeled
-T were found at 6 and 48 h (P < 0.05). These data demonstrate that there are differences in the uptake of newly absorbed
-T into blood components in hyperlipidemia. Because these blood components are functionally affected by vitamin E, reduced uptake of
-T may be relevant to the pathogenesis of atherosclerosis.
KEY WORDS: deuterated tocopherol biokinetics blood cells hyperlipidemia
This article has been cited by other articles:
![]() |
A. J Clifford, F. F de Moura, C. C Ho, J. C Chuang, J. Follett, J. G Fadel, and J. A Novotny A feasibility study quantifying in vivo human {alpha}-tocopherol metabolism Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1430 - 1441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W Clarke, N. C Ward, J. H. Wu, J. M Hodgson, I. B Puddey, and K. D Croft Supplementation with mixed tocopherols increases serum and blood cell {gamma}-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes Am. J. Clinical Nutrition, January 1, 2006; 83(1): 95 - 102. [Abstract] [Full Text] [PDF] |
||||